Found 0 matching trials
Cognitive Stimulation and Sleep Quality. An Innovative Intervention for Insomnia NA The purposes of this study are a) to investigate the effect of a personaliz...
Show More Location
Hospital Universitario de la Ribera
Learn More & Join Trial
Software-based Modification of Hand Tremors in XR NA The following trial evaluates the effect of Tremor Stabilization Algorithms...
Show More Learn More & Join Trial
Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure NA The purpose of this study is to characterize the feasibility and impact of ...
Show More Learn More & Join Trial
Teleoperation Experimental Comparison With Able-bodied Subjects NA To compare the use of the semi-autonomous control algorithm (condition 1) w...
Show More Location
University of Colorado Boulder
Learn More & Join Trial
The Predict H Trial NA The aim of the study is to determine whether a goal-directed algorithm base...
Show More Location
Hospital Universitario de Jerez de la Frontera
Learn More & Join Trial
Mindfulness Training and Respiration Biosignal Feedback - Study 2 NA The goal of this research is to test usability and user satisfaction with a...
Show More Learn More & Join Trial
A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer NA The Dip Home-Based Dipstick Analyzer (henceforth HBDA) is composed of a kit...
Show More Location
Atlanta Center for Medical Research
Learn More & Join Trial
AI-Powered CURAᵀᴹ Application for Identifying At-Risk Pregnancies in Obstetric Management NA It is important to identify high pregnancies early through screening so tha...
Show More Location
National University Hospital
Learn More & Join Trial
Digital Engagement for Lifelong Health NA The DELPHI project (Digital Engagement for Lifelong Prevention and Health I...
Show More Location
Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)
Learn More & Join Trial
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism PHASE3 This trial has a treatment duration of 78 weeks and will include adult part...
Show More Location
Ascendis Pharma Investigational Site
Learn More & Join Trial